Steroids and/or Cytotoxic Agents Should Be Used Early in the Management of Patients with IPF -- The Con Argument
The recently published American Thoracic Society/European Respiratory Society statement distinguishes idiopathic pulmonary fibrosis (IPF), also known as usual interstitial pneumonia (UIP), from the other idiopathic interstitial pneumonias (IIPs) (1). Although the current classification of IIPs i...
Main Author: | Stephen K Field |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2004-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2004/812840 |
Similar Items
-
Steroids and/or Cytotoxic Agents Should Be Used Early in the Management of Patients with IPF -- The Pro Argument
by: Sat Sharma
Published: (2004-01-01) -
Combination of ICSs and LABAs Should Be Used in the Management of Patients with COPD -- The Con Argument
by: Jeremy Road
Published: (2004-01-01) -
Development of the ATAQ-IPF: a tool to assess quality of life in IPF
by: Brown Kevin K, et al.
Published: (2010-07-01) -
IPF : causes and consequences
by: Harris, Jessica M.
Published: (2009) -
Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
by: Helen E. Jo, et al.
Published: (2019-05-01)